Searched for
SUNOVION
Lupin launches generic medication in US marketDrug firm Lupin on Tuesday said it has launched a generic anti-psychotic medication in the US market. The company's product, in strengths o...- Lupin inks pact to acquire two inhalation brands from Sunovion for USD 75 mnThe acquisition of these two brands will expand the company's inhalation product portfolio in the US and strengthen its presence in the res...
- Cipla gets USFDA nod for inhalation productThe company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mc...
- Glenmark Pharma gets USFDA nod for inhalation productGlenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Arformoterol Tartrate In...
- Alembic Pharma gets USFDA nod for bipolar depression drugThe approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals In...
- Unichem Labs gets USFDA nod to market generic capsulesThe company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg fr...
- Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nodThe company has started selling 1 mg, 2 mg and 3 mg tablets of Eszopiclone, a generic version of Lunesta, a sedative drug that is used for ...
- Dr Reddy's Laboratories will infringe on Lunesta's patent: US court of appealThe United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the paten...
- Sensex reverses gains: Top eleven stocks in focusThe BSE Sensex quickly reversed gains in mid-morning trade and slipped in red. Take a look at top eleven stocks in focus.
- Dr Reddy's under pressure on losing appeal for LunestaDr Reddy's Laboratories were witnessing profit booking on reports that the company has lost a patent case for generic version of Lunesta.
- Eleven stocks in focus in Friday morning tradeIndian markets are likely to trade in a range. Here is a list of eleven stocks which are likely to be in focus in trade today.
- Lupin settles litigation over Lunesta with Japanese firmDrug firm Lupin on Monday said it has settled ongoing litigation over Lunesta tablets, used in treating insomnia, with Japan-based Dainippo...
- Lupin settles litigation over Lunesta tablets; stock upPharma major Lupin and its subsidiary Lupin Pharmaceuticals Inc have settled ongoing litigation with Sunovion Pharmaceuticals over Lunesta ...
Load More
